{"data":[{"accessionNo":"0001193125-26-352649","formType":"SCHEDULE 13G/A","amendmentNo":1,"issuerCik":"0001382101","issuerName":"SUTRO BIOPHARMA, INC.","ticker":"STRO","cusip":"869367201","securityClass":"Common stock, $0.001 par value","eventDate":"2026-06-30","reportingPerson":"Joseph Edelman","reportingCik":null,"personType":"IN","sharesOwned":1304846,"percentOfClass":7.9,"filedAt":"2026-08-14","canonicalUrl":"https://xoomar.com/markets/stocks/stro"},{"accessionNo":"0001193125-26-352649","formType":"SCHEDULE 13G/A","amendmentNo":1,"issuerCik":"0001382101","issuerName":"SUTRO BIOPHARMA, INC.","ticker":"STRO","cusip":"869367201","securityClass":"Common stock, $0.001 par value","eventDate":"2026-06-30","reportingPerson":"Perceptive Life Sciences Master Fund, Ltd.","reportingCik":null,"personType":"CO","sharesOwned":1304846,"percentOfClass":7.9,"filedAt":"2026-08-14","canonicalUrl":"https://xoomar.com/markets/stocks/stro"},{"accessionNo":"0001193125-26-352649","formType":"SCHEDULE 13G/A","amendmentNo":1,"issuerCik":"0001382101","issuerName":"SUTRO BIOPHARMA, INC.","ticker":"STRO","cusip":"869367201","securityClass":"Common stock, $0.001 par value","eventDate":"2026-06-30","reportingPerson":"Perceptive Advisors LLC","reportingCik":null,"personType":"IA","sharesOwned":1304846,"percentOfClass":7.9,"filedAt":"2026-08-14","canonicalUrl":"https://xoomar.com/markets/stocks/stro"},{"accessionNo":"0000919574-26-005498","formType":"SCHEDULE 13G/A","amendmentNo":1,"issuerCik":"0001382101","issuerName":"SUTRO BIOPHARMA, INC.","ticker":"STRO","cusip":"869367201","securityClass":"Common Stock, par value $0.001 per share","eventDate":"2026-06-30","reportingPerson":"Point72 Asset Management, L.P.","reportingCik":null,"personType":"PN","sharesOwned":237827,"percentOfClass":1.4,"filedAt":"2026-08-14","canonicalUrl":"https://xoomar.com/markets/stocks/stro"},{"accessionNo":"0000919574-26-005498","formType":"SCHEDULE 13G/A","amendmentNo":1,"issuerCik":"0001382101","issuerName":"SUTRO BIOPHARMA, INC.","ticker":"STRO","cusip":"869367201","securityClass":"Common Stock, par value $0.001 per share","eventDate":"2026-06-30","reportingPerson":"Point72 Capital Advisors, Inc.","reportingCik":null,"personType":"CO","sharesOwned":237827,"percentOfClass":1.4,"filedAt":"2026-08-14","canonicalUrl":"https://xoomar.com/markets/stocks/stro"},{"accessionNo":"0000919574-26-005498","formType":"SCHEDULE 13G/A","amendmentNo":1,"issuerCik":"0001382101","issuerName":"SUTRO BIOPHARMA, INC.","ticker":"STRO","cusip":"869367201","securityClass":"Common Stock, par value $0.001 per share","eventDate":"2026-06-30","reportingPerson":"Steven A. Cohen","reportingCik":null,"personType":"IN","sharesOwned":237827,"percentOfClass":1.4,"filedAt":"2026-08-14","canonicalUrl":"https://xoomar.com/markets/stocks/stro"},{"accessionNo":"0002012383-26-003158","formType":"SCHEDULE 13G","amendmentNo":null,"issuerCik":"0001382101","issuerName":"SUTRO BIOPHARMA, INC.","ticker":"STRO","cusip":"869367201","securityClass":"Common Stock","eventDate":"2026-06-30","reportingPerson":"BlackRock, Inc.","reportingCik":null,"personType":"HC","sharesOwned":1065366,"percentOfClass":6.4,"filedAt":"2026-07-30","canonicalUrl":"https://xoomar.com/markets/stocks/stro"},{"accessionNo":"0001699737-26-000010","formType":"SCHEDULE 13G","amendmentNo":null,"issuerCik":"0001382101","issuerName":"Sutro Biopharma, Inc.","ticker":"STRO","cusip":"869367201","securityClass":"Common Stock, $0.001 par value per share","eventDate":"2026-02-11","reportingPerson":"Srinivas Akkaraju","reportingCik":null,"personType":"IN","sharesOwned":1062872,"percentOfClass":6.4,"filedAt":"2026-05-15","canonicalUrl":"https://xoomar.com/markets/stocks/stro"},{"accessionNo":"0001907884-26-000008","formType":"SCHEDULE 13G/A","amendmentNo":1,"issuerCik":"0001382101","issuerName":"Sutro Biopharma, Inc.","ticker":"STRO","cusip":"869367102","securityClass":"Common stock, $0.001 par value","eventDate":"2026-03-31","reportingPerson":"Kynam Capital Management, LP","reportingCik":null,"personType":"IA","sharesOwned":0,"percentOfClass":5.27,"filedAt":"2026-05-15","canonicalUrl":"https://xoomar.com/markets/stocks/stro"},{"accessionNo":"0001907884-26-000008","formType":"SCHEDULE 13G/A","amendmentNo":1,"issuerCik":"0001382101","issuerName":"Sutro Biopharma, Inc.","ticker":"STRO","cusip":"869367102","securityClass":"Common stock, $0.001 par value","eventDate":"2026-03-31","reportingPerson":"Yue Tang","reportingCik":null,"personType":"IN","sharesOwned":0,"percentOfClass":5.27,"filedAt":"2026-05-15","canonicalUrl":"https://xoomar.com/markets/stocks/stro"},{"accessionNo":"0001907884-26-000008","formType":"SCHEDULE 13G/A","amendmentNo":1,"issuerCik":"0001382101","issuerName":"Sutro Biopharma, Inc.","ticker":"STRO","cusip":"869367102","securityClass":"Common stock, $0.001 par value","eventDate":"2026-03-31","reportingPerson":"Kynam Capital Management GP, LLC","reportingCik":null,"personType":"OO","sharesOwned":0,"percentOfClass":5.27,"filedAt":"2026-05-15","canonicalUrl":"https://xoomar.com/markets/stocks/stro"},{"accessionNo":"0001699737-26-000010","formType":"SCHEDULE 13G","amendmentNo":null,"issuerCik":"0001382101","issuerName":"Sutro Biopharma, Inc.","ticker":"STRO","cusip":"869367201","securityClass":"Common Stock, $0.001 par value per share","eventDate":"2026-02-11","reportingPerson":"Samsara Opportunity Fund, L.P.","reportingCik":null,"personType":"PN","sharesOwned":643777,"percentOfClass":3.9,"filedAt":"2026-05-15","canonicalUrl":"https://xoomar.com/markets/stocks/stro"},{"accessionNo":"0001699737-26-000010","formType":"SCHEDULE 13G","amendmentNo":null,"issuerCik":"0001382101","issuerName":"Sutro Biopharma, Inc.","ticker":"STRO","cusip":"869367201","securityClass":"Common Stock, $0.001 par value per share","eventDate":"2026-02-11","reportingPerson":"Samsara Opportunity Fund GP, LLC","reportingCik":null,"personType":"OO","sharesOwned":643777,"percentOfClass":3.9,"filedAt":"2026-05-15","canonicalUrl":"https://xoomar.com/markets/stocks/stro"},{"accessionNo":"0001699737-26-000010","formType":"SCHEDULE 13G","amendmentNo":null,"issuerCik":"0001382101","issuerName":"Sutro Biopharma, Inc.","ticker":"STRO","cusip":"869367201","securityClass":"Common Stock, $0.001 par value per share","eventDate":"2026-02-11","reportingPerson":"Samsara BioCapital GP, LLC","reportingCik":null,"personType":"OO","sharesOwned":419095,"percentOfClass":2.5,"filedAt":"2026-05-15","canonicalUrl":"https://xoomar.com/markets/stocks/stro"},{"accessionNo":"0001699737-26-000010","formType":"SCHEDULE 13G","amendmentNo":null,"issuerCik":"0001382101","issuerName":"Sutro Biopharma, Inc.","ticker":"STRO","cusip":"869367201","securityClass":"Common Stock, $0.001 par value per share","eventDate":"2026-02-11","reportingPerson":"Samsara BioCapital, L.P.","reportingCik":null,"personType":"PN","sharesOwned":419095,"percentOfClass":2.5,"filedAt":"2026-05-15","canonicalUrl":"https://xoomar.com/markets/stocks/stro"},{"accessionNo":"0001011438-26-000314","formType":"SCHEDULE 13G/A","amendmentNo":2,"issuerCik":"0001382101","issuerName":"Sutro Biopharma, Inc.","ticker":"STRO","cusip":"869367201","securityClass":"Common stock, $0.001 par value per share","eventDate":"2026-03-31","reportingPerson":"Affinity Asset Advisors, LLC","reportingCik":null,"personType":"IA,OO","sharesOwned":1069519,"percentOfClass":6.5,"filedAt":"2026-05-14","canonicalUrl":"https://xoomar.com/markets/stocks/stro"},{"accessionNo":"0001011438-26-000314","formType":"SCHEDULE 13G/A","amendmentNo":2,"issuerCik":"0001382101","issuerName":"Sutro Biopharma, Inc.","ticker":"STRO","cusip":"869367201","securityClass":"Common stock, $0.001 par value per share","eventDate":"2026-03-31","reportingPerson":"Michael Cho","reportingCik":null,"personType":"IN,HC","sharesOwned":1069519,"percentOfClass":6.5,"filedAt":"2026-05-14","canonicalUrl":"https://xoomar.com/markets/stocks/stro"},{"accessionNo":"0000919574-26-002548","formType":"SCHEDULE 13G","amendmentNo":null,"issuerCik":"0001382101","issuerName":"SUTRO BIOPHARMA, INC.","ticker":"STRO","cusip":"869367201","securityClass":"Common Stock, par value $0.001 per share","eventDate":"2026-04-24","reportingPerson":"Point72 Capital Advisors, Inc.","reportingCik":null,"personType":"CO","sharesOwned":946829,"percentOfClass":5.7,"filedAt":"2026-05-01","canonicalUrl":"https://xoomar.com/markets/stocks/stro"},{"accessionNo":"0000919574-26-002548","formType":"SCHEDULE 13G","amendmentNo":null,"issuerCik":"0001382101","issuerName":"SUTRO BIOPHARMA, INC.","ticker":"STRO","cusip":"869367201","securityClass":"Common Stock, par value $0.001 per share","eventDate":"2026-04-24","reportingPerson":"Point72 Asset Management, L.P.","reportingCik":null,"personType":"PN","sharesOwned":946829,"percentOfClass":5.7,"filedAt":"2026-05-01","canonicalUrl":"https://xoomar.com/markets/stocks/stro"},{"accessionNo":"0000919574-26-002548","formType":"SCHEDULE 13G","amendmentNo":null,"issuerCik":"0001382101","issuerName":"SUTRO BIOPHARMA, INC.","ticker":"STRO","cusip":"869367201","securityClass":"Common Stock, par value $0.001 per share","eventDate":"2026-04-24","reportingPerson":"Steven A. Cohen","reportingCik":null,"personType":"IN","sharesOwned":946829,"percentOfClass":5.7,"filedAt":"2026-05-01","canonicalUrl":"https://xoomar.com/markets/stocks/stro"},{"accessionNo":"0001193125-26-166842","formType":"SCHEDULE 13G","amendmentNo":null,"issuerCik":"0001382101","issuerName":"SUTRO BIOPHARMA, INC.","ticker":"STRO","cusip":"869367201","securityClass":"Common stock, $0.001 par value","eventDate":"2026-04-14","reportingPerson":"Perceptive Advisors LLC","reportingCik":null,"personType":"IA","sharesOwned":898025,"percentOfClass":5.4,"filedAt":"2026-04-21","canonicalUrl":"https://xoomar.com/markets/stocks/stro"},{"accessionNo":"0001193125-26-166842","formType":"SCHEDULE 13G","amendmentNo":null,"issuerCik":"0001382101","issuerName":"SUTRO BIOPHARMA, INC.","ticker":"STRO","cusip":"869367201","securityClass":"Common stock, $0.001 par value","eventDate":"2026-04-14","reportingPerson":"Joseph Edelman","reportingCik":null,"personType":"IN","sharesOwned":898025,"percentOfClass":5.4,"filedAt":"2026-04-21","canonicalUrl":"https://xoomar.com/markets/stocks/stro"},{"accessionNo":"0001193125-26-166842","formType":"SCHEDULE 13G","amendmentNo":null,"issuerCik":"0001382101","issuerName":"SUTRO BIOPHARMA, INC.","ticker":"STRO","cusip":"869367201","securityClass":"Common stock, $0.001 par value","eventDate":"2026-04-14","reportingPerson":"Perceptive Life Sciences Master Fund, Ltd.","reportingCik":null,"personType":"CO","sharesOwned":898025,"percentOfClass":5.4,"filedAt":"2026-04-21","canonicalUrl":"https://xoomar.com/markets/stocks/stro"},{"accessionNo":"0001104659-26-046182","formType":"SCHEDULE 13G/A","amendmentNo":1,"issuerCik":"0001382101","issuerName":"Sutro Biopharma, Inc.","ticker":"STRO","cusip":"869367201","securityClass":"Common Stock, par value $0.001 per share","eventDate":"2026-03-31","reportingPerson":"Millennium Management LLC","reportingCik":null,"personType":"OO","sharesOwned":210378,"percentOfClass":1.3,"filedAt":"2026-04-21","canonicalUrl":"https://xoomar.com/markets/stocks/stro"},{"accessionNo":"0001104659-26-046182","formType":"SCHEDULE 13G/A","amendmentNo":1,"issuerCik":"0001382101","issuerName":"Sutro Biopharma, Inc.","ticker":"STRO","cusip":"869367201","securityClass":"Common Stock, par value $0.001 per share","eventDate":"2026-03-31","reportingPerson":"Millennium Group Management LLC","reportingCik":null,"personType":"OO","sharesOwned":210378,"percentOfClass":1.3,"filedAt":"2026-04-21","canonicalUrl":"https://xoomar.com/markets/stocks/stro"},{"accessionNo":"0001104659-26-046182","formType":"SCHEDULE 13G/A","amendmentNo":1,"issuerCik":"0001382101","issuerName":"Sutro Biopharma, Inc.","ticker":"STRO","cusip":"869367201","securityClass":"Common Stock, par value $0.001 per share","eventDate":"2026-03-31","reportingPerson":"Israel A. Englander","reportingCik":null,"personType":"IN","sharesOwned":210378,"percentOfClass":1.3,"filedAt":"2026-04-21","canonicalUrl":"https://xoomar.com/markets/stocks/stro"},{"accessionNo":"0000921895-26-000502","formType":"SCHEDULE 13G","amendmentNo":null,"issuerCik":"0001382101","issuerName":"SUTRO BIOPHARMA, INC.","ticker":"STRO","cusip":null,"securityClass":"Common Stock, $0.001 par value","eventDate":"2026-02-10","reportingPerson":"LAMPERT MARK N","reportingCik":null,"personType":"IN","sharesOwned":1251788,"percentOfClass":7.6,"filedAt":"2026-02-18","canonicalUrl":"https://xoomar.com/markets/stocks/stro"},{"accessionNo":"0000921895-26-000502","formType":"SCHEDULE 13G","amendmentNo":null,"issuerCik":"0001382101","issuerName":"SUTRO BIOPHARMA, INC.","ticker":"STRO","cusip":null,"securityClass":"Common Stock, $0.001 par value","eventDate":"2026-02-10","reportingPerson":"BVF PARTNERS L P/IL","reportingCik":null,"personType":"IA,PN","sharesOwned":1251788,"percentOfClass":7.6,"filedAt":"2026-02-18","canonicalUrl":"https://xoomar.com/markets/stocks/stro"},{"accessionNo":"0000921895-26-000502","formType":"SCHEDULE 13G","amendmentNo":null,"issuerCik":"0001382101","issuerName":"SUTRO BIOPHARMA, INC.","ticker":"STRO","cusip":null,"securityClass":"Common Stock, $0.001 par value","eventDate":"2026-02-10","reportingPerson":"BVF INC/IL","reportingCik":null,"personType":"CO","sharesOwned":1251788,"percentOfClass":7.6,"filedAt":"2026-02-18","canonicalUrl":"https://xoomar.com/markets/stocks/stro"},{"accessionNo":"0000921895-26-000502","formType":"SCHEDULE 13G","amendmentNo":null,"issuerCik":"0001382101","issuerName":"SUTRO BIOPHARMA, INC.","ticker":"STRO","cusip":null,"securityClass":"Common Stock, $0.001 par value","eventDate":"2026-02-10","reportingPerson":"BVF GP HOLDINGS LLC","reportingCik":null,"personType":"OO","sharesOwned":1157609,"percentOfClass":7,"filedAt":"2026-02-18","canonicalUrl":"https://xoomar.com/markets/stocks/stro"},{"accessionNo":"0000921895-26-000502","formType":"SCHEDULE 13G","amendmentNo":null,"issuerCik":"0001382101","issuerName":"SUTRO BIOPHARMA, INC.","ticker":"STRO","cusip":null,"securityClass":"Common Stock, $0.001 par value","eventDate":"2026-02-10","reportingPerson":"BIOTECHNOLOGY VALUE FUND L P","reportingCik":null,"personType":"PN","sharesOwned":668693,"percentOfClass":4.1,"filedAt":"2026-02-18","canonicalUrl":"https://xoomar.com/markets/stocks/stro"},{"accessionNo":"0000921895-26-000502","formType":"SCHEDULE 13G","amendmentNo":null,"issuerCik":"0001382101","issuerName":"SUTRO BIOPHARMA, INC.","ticker":"STRO","cusip":null,"securityClass":"Common Stock, $0.001 par value","eventDate":"2026-02-10","reportingPerson":"BVF I GP LLC","reportingCik":null,"personType":"OO","sharesOwned":668693,"percentOfClass":4.1,"filedAt":"2026-02-18","canonicalUrl":"https://xoomar.com/markets/stocks/stro"},{"accessionNo":"0000921895-26-000502","formType":"SCHEDULE 13G","amendmentNo":null,"issuerCik":"0001382101","issuerName":"SUTRO BIOPHARMA, INC.","ticker":"STRO","cusip":null,"securityClass":"Common Stock, $0.001 par value","eventDate":"2026-02-10","reportingPerson":"BVF II GP LLC","reportingCik":null,"personType":"OO","sharesOwned":488916,"percentOfClass":3,"filedAt":"2026-02-18","canonicalUrl":"https://xoomar.com/markets/stocks/stro"},{"accessionNo":"0000921895-26-000502","formType":"SCHEDULE 13G","amendmentNo":null,"issuerCik":"0001382101","issuerName":"SUTRO BIOPHARMA, INC.","ticker":"STRO","cusip":null,"securityClass":"Common Stock, $0.001 par value","eventDate":"2026-02-10","reportingPerson":"BIOTECHNOLOGY VALUE FUND II LP","reportingCik":null,"personType":"PN","sharesOwned":488916,"percentOfClass":3,"filedAt":"2026-02-18","canonicalUrl":"https://xoomar.com/markets/stocks/stro"},{"accessionNo":"0000921895-26-000502","formType":"SCHEDULE 13G","amendmentNo":null,"issuerCik":"0001382101","issuerName":"SUTRO BIOPHARMA, INC.","ticker":"STRO","cusip":null,"securityClass":"Common Stock, $0.001 par value","eventDate":"2026-02-10","reportingPerson":"Biotechnology Value Trading Fund OS LP","reportingCik":null,"personType":"PN","sharesOwned":75359,"percentOfClass":0.5,"filedAt":"2026-02-18","canonicalUrl":"https://xoomar.com/markets/stocks/stro"},{"accessionNo":"0000921895-26-000502","formType":"SCHEDULE 13G","amendmentNo":null,"issuerCik":"0001382101","issuerName":"SUTRO BIOPHARMA, INC.","ticker":"STRO","cusip":null,"securityClass":"Common Stock, $0.001 par value","eventDate":"2026-02-10","reportingPerson":"BVF Partners OS Ltd.","reportingCik":null,"personType":"CO","sharesOwned":75359,"percentOfClass":0.5,"filedAt":"2026-02-18","canonicalUrl":"https://xoomar.com/markets/stocks/stro"},{"accessionNo":"0000919574-26-000953","formType":"SCHEDULE 13G/A","amendmentNo":5,"issuerCik":"0001382101","issuerName":"Sutro Biopharma, Inc.","ticker":"STRO","cusip":null,"securityClass":"Common Stock, $0.001 par value","eventDate":"2025-12-31","reportingPerson":"SUVRETTA CAPITAL MANAGEMENT, LLC","reportingCik":null,"personType":"IA,OO","sharesOwned":0,"percentOfClass":0,"filedAt":"2026-02-13","canonicalUrl":"https://xoomar.com/markets/stocks/stro"},{"accessionNo":"0000919574-26-000953","formType":"SCHEDULE 13G/A","amendmentNo":5,"issuerCik":"0001382101","issuerName":"Sutro Biopharma, Inc.","ticker":"STRO","cusip":null,"securityClass":"Common Stock, $0.001 par value","eventDate":"2025-12-31","reportingPerson":"AVERILL MASTER FUND, LTD.","reportingCik":null,"personType":"CO","sharesOwned":0,"percentOfClass":0,"filedAt":"2026-02-13","canonicalUrl":"https://xoomar.com/markets/stocks/stro"},{"accessionNo":"0000919574-26-000953","formType":"SCHEDULE 13G/A","amendmentNo":5,"issuerCik":"0001382101","issuerName":"Sutro Biopharma, Inc.","ticker":"STRO","cusip":null,"securityClass":"Common Stock, $0.001 par value","eventDate":"2025-12-31","reportingPerson":"AARON COWEN","reportingCik":null,"personType":"HC,IN","sharesOwned":0,"percentOfClass":0,"filedAt":"2026-02-13","canonicalUrl":"https://xoomar.com/markets/stocks/stro"},{"accessionNo":"0000919574-26-000954","formType":"SCHEDULE 13G/A","amendmentNo":5,"issuerCik":"0001382101","issuerName":"Sutro Biopharma, Inc.","ticker":"STRO","cusip":null,"securityClass":"Common Stock, $0.001 par value","eventDate":"2025-12-31","reportingPerson":"SUVRETTA CAPITAL MANAGEMENT, LLC","reportingCik":null,"personType":"IA,OO","sharesOwned":0,"percentOfClass":0,"filedAt":"2026-02-13","canonicalUrl":"https://xoomar.com/markets/stocks/stro"},{"accessionNo":"0000919574-26-000954","formType":"SCHEDULE 13G/A","amendmentNo":5,"issuerCik":"0001382101","issuerName":"Sutro Biopharma, Inc.","ticker":"STRO","cusip":null,"securityClass":"Common Stock, $0.001 par value","eventDate":"2025-12-31","reportingPerson":"AVERILL MASTER FUND, LTD.","reportingCik":null,"personType":"CO","sharesOwned":0,"percentOfClass":0,"filedAt":"2026-02-13","canonicalUrl":"https://xoomar.com/markets/stocks/stro"},{"accessionNo":"0000919574-26-000954","formType":"SCHEDULE 13G/A","amendmentNo":5,"issuerCik":"0001382101","issuerName":"Sutro Biopharma, Inc.","ticker":"STRO","cusip":null,"securityClass":"Common Stock, $0.001 par value","eventDate":"2025-12-31","reportingPerson":"AARON COWEN","reportingCik":null,"personType":"HC,IN","sharesOwned":0,"percentOfClass":0,"filedAt":"2026-02-13","canonicalUrl":"https://xoomar.com/markets/stocks/stro"},{"accessionNo":"0001315863-26-000098","formType":"SCHEDULE 13G/A","amendmentNo":1,"issuerCik":"0001382101","issuerName":"Sutro Biopharma, Inc.","ticker":"STRO","cusip":null,"securityClass":"Common Stock, $0.001 par value per share","eventDate":"2026-01-22","reportingPerson":"Affinity Asset Advisors, LLC","reportingCik":null,"personType":"IA,OO","sharesOwned":748382,"percentOfClass":8.8,"filedAt":"2026-01-29","canonicalUrl":"https://xoomar.com/markets/stocks/stro"},{"accessionNo":"0001315863-26-000098","formType":"SCHEDULE 13G/A","amendmentNo":1,"issuerCik":"0001382101","issuerName":"Sutro Biopharma, Inc.","ticker":"STRO","cusip":null,"securityClass":"Common Stock, $0.001 par value per share","eventDate":"2026-01-22","reportingPerson":"Michael Cho","reportingCik":null,"personType":"IN,HC","sharesOwned":748382,"percentOfClass":8.8,"filedAt":"2026-01-29","canonicalUrl":"https://xoomar.com/markets/stocks/stro"},{"accessionNo":"0001999371-25-015943","formType":"SCHEDULE 13G","amendmentNo":null,"issuerCik":"0001382101","issuerName":"SUTRO BIOPHARMA, INC.","ticker":"STRO","cusip":null,"securityClass":"Common Stock, par value $0.001 per share","eventDate":"2025-10-16","reportingPerson":"Affinity Healthcare Fund, LP","reportingCik":null,"personType":"PN","sharesOwned":6583772,"percentOfClass":7.77,"filedAt":"2025-10-23","canonicalUrl":"https://xoomar.com/markets/stocks/stro"},{"accessionNo":"0001999371-25-015943","formType":"SCHEDULE 13G","amendmentNo":null,"issuerCik":"0001382101","issuerName":"SUTRO BIOPHARMA, INC.","ticker":"STRO","cusip":null,"securityClass":"Common Stock, par value $0.001 per share","eventDate":"2025-10-16","reportingPerson":"Affinity Asset Advisors, LLC","reportingCik":null,"personType":"IA","sharesOwned":6583772,"percentOfClass":7.77,"filedAt":"2025-10-23","canonicalUrl":"https://xoomar.com/markets/stocks/stro"}],"updatedAt":"2026-11-04T01:21:58.666Z","source":"xoomar.com","docs":"https://xoomar.com/markets/api","license":"https://xoomar.com/terms","attribution":"Credit XOOMAR with a link to the dataset page on xoomar.com when you republish this data","canonicalUrl":"https://xoomar.com/markets/stocks/stro","meta":{"source":"SEC","sourceAttribution":"Schedule 13D and 13G data: SEC.","notice":"10 requests a minute without a key, 30 with a free key. Get a free key at https://xoomar.com/signup?utm_source=api, register your app at https://xoomar.com/developers/register?utm_source=api, and credit the data as \"Data: XOOMAR\" together with the sourceAttribution line."}}